Real Time Screeners Intraday Screeners now on Real Time Data (Updated every 5 mins)
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Glaxosmithkline Pharmaceuticals , Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Glaxosmithkline Pharmaceuticals Ltd.

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

EOD Share Price1210.25
Previous Share Price1257.4
Price Change -47.15
Change % -3.75%
Volume54.27 K
Five Day Avg Vol37.14 K
Last Business Date01-Apr-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week 13.55 1.13
Two Weeks -18.25 -1.49
One Month -95.75 -7.33
Three Months -421.60 -25.84
Six Months -170.20 -12.33
One Year -89.35 -6.88

Highs / Lows

One Week1288.91122.05
Two Weeks1288.9973.0
One Month1340.0962.65
Three Months1748.0962.65
Six Months1748.0962.65
One Year1748.0962.65

Key Moving Average

5 Days 1214.721215.36
15 Days 1206.771223.23
20 Days 1233.181237.95
50 Days 1360.891333.5
100 Days 1499.481402.46
200 Days 1404.71413.52
Detailed MA Analysis of GLAXO ...

Key Technical Indicators

MACD -41.86
RSI 50.71
RSI (Smooth) 44.19
ADX 56.88
Chaikin Money Flow 0.122
Williams %R -26.17
PSAR 979.32
Detailed Tech Analysis GLAXO ...

Financial Data Highlights

Market Cap19934.75
Book Value/ Share138.476
Enterprise Value3693.65
Revenue TTM3199.39
Gross Profit TTM1749.27
Revenue /Share TTM188.89
Consensus Target2310.82
Key Financial Highlights GLAXO ...

Financial Ratios of GLAXO

Div Yield1.67
Trailing PE195.97
Forward PE20.65
Key Financial Ratios of GLAXO ...

Key Profit & Loss Data

Net Inc 445.39 26.99 %
Ops Income557.06 16.73 %
Revenue3128.12 8.94 %
Ops Expense2571.06 7.39 %
PBT682.67 26.43 %
Gross Profit1749.27 8.50 %
Div Paid-296.46 16.67 %
Key P&L GLAXO ...

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR119.359.86
Week PR138.9011.48
Month PR119.359.86
5 Day Period94.888.21
10 Day Period107.959.89
5 Week Period222.0521.90
3 Months Period392.1535.50
Price Range /Volatility GLAXO ...

Highlights & Chart Patterns of Glaxosmithkline Pharmaceuticals Ltd.

Stock has jumped by more than 10% in last two weeks from its lowest level of 973.0 dt 25-Mar-20
Stock has jumped by more than 15% in last One Month from its lowest level of 962.65 dt 13-Mar-20.
Stock has jumped by more than 25% in last three Month from its lowest level of 962.65 dt 13-Mar-20.
Stock has fallen by more than 25% in last three Month from its highest level of 1748.0 dt 29-Jan-20.
Share is making strong moves on recent weekly chart. Such movements may give an opportunity for short term trading.
Share is making strong moves on recent Monthly chart. Such movements may give an opportunity for short term trading.
As Per ADX, stock is in strong trend with ADX of 56.8764 and is trending for 45 Days
More Chart Patterns Glaxosmithkline Pharmaceuticals Ltd. ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Glaxosmithkline Pharmaceuticals Ltd.

Date Open High Low Close Volume
01-Apr-20 1255.00 1269.35 1150.00 1210.25 54266
31-Mar-20 1245.00 1288.90 1221.00 1257.40 37373
30-Mar-20 1179.55 1232.00 1165.00 1227.30 26313
27-Mar-20 1239.00 1247.30 1122.05 1179.55 37410
26-Mar-20 1198.00 1240.00 1175.05 1199.10 30320
25-Mar-20 1149.00 1205.00 973.00 1196.70 30972
24-Mar-20 1120.00 1160.00 1100.00 1139.80 20245
23-Mar-20 1100.00 1189.95 1053.80 1101.85 42795
20-Mar-20 1202.00 1275.00 1176.05 1224.95 31931
19-Mar-20 1225.00 1225.00 1150.00 1191.50 57519
About GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines worldwide. The company offers prescription and non-prescription drugs for asthma, infectious diseases, mental health, and digestive conditions, as well as anti-infective, gastrointestinal, dermatology, analgesic, and respiratory diseases. It also provides vaccines for the treatment of cancer, as well as prevention of hepatitis A, hepatitis B, invasive disease caused by H. Influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus diarrhea, cervical cancer, invasive pneumococcal, and others; and consumer healthcare products. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was founded in 1924 and is headquartered in Mumbai, India.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on Real Time Data (Updated every 5 Mins). All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)

All Rights Reserved By Mintnovate Market Research Pvt Ltd.